Sex-specific differences in myocardial injury incidence after COVID-19 mRNA-1273 Booster Vaccination

Among 777 participants, median age 37 years, 69.5% women, 40 participants (5.1% [95%CI, 3.7%–7.0%]) had elevated hs-cTnT concentration on day 3 and mRNA-1273 vaccine-associated myocardial injury was adjudicated in 22 participants (2.8% [95%CI, 1.7%–4.3%]). Twenty cases occurred in women (3.7% [95%CI, 2.3%–5.7%]), two in men (0.8% [95%CI, 0.1%–3.0%]).
https://onlinelibrary.wiley.com/doi/10.1002/ejhf.2978

Podnety prijímame na adrese toluen@minv.sk